Wide, warm Kampala clinic or community shot. A health worker with a patient, daylight, real place.
SRHIN Uganda brings evidence, technology and community trust to the health problems that hit underserved Ugandans hardest, starting with the patients Kampala's tuberculosis services struggle to keep in treatment.
SRHIN has worked since 2017 to reach the people health systems leave behind, in slums, rural areas and displacement camps across Africa. Uganda is our newest chapter, and we are starting where the need is measurable and the response is proven.
Free-licence stand-in
SRHIN Uganda team in a planning session or field visit. Faces build trust faster than logos.
About 87,000 people in Uganda develop TB every year, and the country carries one of the few TB burdens in the region that has been rising rather than falling.
The medicines work. The problem sits later in the journey: roughly one in four Ugandan TB patients stop taking their treatment before they are cured. When people drop off, the infection returns, spreads further, and grows resistant to the drugs that once would have cured it.
We built our first Uganda programme around that exact gap.
Infectious disease is where we lead in Uganda. The other three are what make that work stick.
We take proven interventions to the point where they usually break down: whether a patient actually completes their treatment. Our first programme tackles TB treatment adherence in Kampala, built to extend to other diseases where staying in care is the real challenge.
Our lead programme →Illness, displacement and poverty carry a mental health cost most systems never count. We bring culturally grounded, community-led support to the same populations we serve, drawing on SRHIN's BraveHeart work in displacement camps.
Low-cost technology, task-shifting and AI stretch scarce health workers further: treatment reminders, multilingual tools, and data that helps teams act earlier. This is how we reach the last mile without waiting for the system to grow.
Lasting change needs owners. We work with government, health facilities and communities so that what we prove can be handed over, funded and scaled, rather than ending when a project ends.
Most TB patients do not stop because they do not care. They stop because they start feeling better, because the side effects are hard, because getting to the clinic costs money they do not have, or because it is easy to forget a daily routine over many months.
Working with two Kampala hospitals that already run the national Directly Observed Therapy strategy, we deliver structured health education built on the Health Belief Model, an approach with strong evidence for improving TB adherence.
Free-licence stand-in
A health education session in progress, or the physical tools laid out: booklet, wristband, diary.
Over four months, patients take part in eight practical sessions that explain what TB is, why finishing treatment matters, and how to handle the parts that make people quit. Every patient leaves with a booklet covering TB, prevention, treatment and a personal adherence action plan.
The programme runs as a randomised controlled trial, so we will know what worked and by how much, not just that we ran it.
Every SRHIN programme rests on three legs. Our Uganda TB programme is all three at once: a community-trusted intervention, tested through a controlled trial, delivered with mobile reminders and digital tools.
We advocate so the right people are at the table, and the work has an owner after we leave.
We research so decisions rest on evidence rather than assumption, and so what we learn adds to the field.
We use technology to reach people the health system cannot reach on foot.
What partners, funders and volunteers ask most about the Uganda work.
SRHIN has worked since 2017 across slums, rural areas and displacement camps in Africa, reaching more than 1.7 million people. Uganda is the newest chapter, starting with TB treatment adherence in Kampala.
About 87,000 people develop TB in Uganda each year, and roughly one in four stop treatment before they are cured. The medicines work; finishing the course is the gap. We started where the need is measurable and the response is proven.
It runs as a randomised controlled trial, delivered through two Kampala hospitals aligned with the national Directly Observed Therapy strategy. We measure results against targets set before we start, rather than assuming impact.
Yes. The programme runs under formal ethical approval and works inside Uganda's existing health structures rather than around them.
You can partner as an organisation, funder or health facility; volunteer as a health professional or student; or donate directly to support patients through treatment. See the options below.
Whether you fund health equity, run a clinic, research infectious disease, or want to give your time, there is a place for you here.